TRPA1 and colitis: In the present study, however, we found that the TRPA1 antagonist HC-030031 as well as genetic deletion of TRPA1 failed to significantly alter the severity of DSS-induced colitis as judged by body weight, colon length, colon weight, colonic MPO activity and disease activity score.